Gabapentin
Product Images NDC 83008-049

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 83008-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Camscanner 01 11 2024 09.59)

Gabapentin Capsules, USP 400 mg label from Quality Care Products, LLC, packaged and distributed in Holland, Ohio. The 60-count bottle contains 400 mg capsules. The label includes storage instructions (68 to 77 degrees F), a barcode, and notes the manufacturer as ScieGen Pharmaceuticals, Inc., Hauppauge, NY. It is marked Rx only with a caution to keep medication out of reach of children.*

FDA Label Image

Figure 1 (Image 01)

A line graph comparing mean pain scores over an 8-week period between placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks from baseline to 8, with annotations marking a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. Gabapentin shows a decreasing trend in pain scores over time compared to placebo.*

FDA Label Image

Figure 2 (Image 02)

A line graph depicting mean pain score over 7 weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis shows weeks from baseline to week 7, and the y-axis shows mean pain score from 0 to 10. The graph illustrates a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Image 03)

A bar graph titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares response rates (%) in two studies for placebo (PBO) and Gabapentin (GBP) at different dosages (3600 mg, 1800 mg, 2400 mg). Values show higher responder proportions with Gabapentin doses compared to placebo, with significance levels indicated by asterisks.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

An illustration showing a formula for calculating creatinine clearance (CLCr), which involves age, weight, serum creatinine levels, and an adjustment factor for female patients.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of gabapentin, depicting its molecular arrangement with a cyclohexane ring and functional groups including amino and carboxyl groups.*

FDA Label Image

Image-09 (Image 09)

A scatter plot comparing percentage difference against daily dose (mg) for Gabapentin in three studies labeled a, b, and c. The x-axis represents daily doses of 600, 900, 1200, and 1800 mg, while the y-axis shows percentage difference from 2% to 22%. Data points for each study are plotted for corresponding doses, illustrating variability across studies.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.